These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 23222714)

  • 21. Versatile prostate cancer treatment with inducible caspase and interleukin-12.
    Nikitina EY; Desai SA; Zhao X; Song W; Luo AZ; Gangula RD; Slawin KM; Spencer DM
    Cancer Res; 2005 May; 65(10):4309-19. PubMed ID: 15899823
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myeloid-derived suppressor cells in inflammatory bowel disease: a new immunoregulatory pathway.
    Haile LA; von Wasielewski R; Gamrekelashvili J; Krüger C; Bachmann O; Westendorf AM; Buer J; Liblau R; Manns MP; Korangy F; Greten TF
    Gastroenterology; 2008 Sep; 135(3):871-81, 881.e1-5. PubMed ID: 18674538
    [TBL] [Abstract][Full Text] [Related]  

  • 23. G Protein-coupled pH-sensing Receptor OGR1 Is a Regulator of Intestinal Inflammation.
    de Vallière C; Wang Y; Eloranta JJ; Vidal S; Clay I; Spalinger MR; Tcymbarevich I; Terhalle A; Ludwig MG; Suply T; Fried M; Kullak-Ublick GA; Frey-Wagner I; Scharl M; Seuwen K; Wagner CA; Rogler G
    Inflamm Bowel Dis; 2015 Jun; 21(6):1269-81. PubMed ID: 25856770
    [TBL] [Abstract][Full Text] [Related]  

  • 24. OGR1/GPR68 Modulates the Severity of Experimental Autoimmune Encephalomyelitis and Regulates Nitric Oxide Production by Macrophages.
    D'Souza CA; Zhao FL; Li X; Xu Y; Dunn SE; Zhang L
    PLoS One; 2016; 11(2):e0148439. PubMed ID: 26828924
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myeloid-derived suppressor cell functionality and interaction with Leishmania major parasites differ in C57BL/6 and BALB/c mice.
    Schmid M; Zimara N; Wege AK; Ritter U
    Eur J Immunol; 2014 Nov; 44(11):3295-306. PubMed ID: 25142017
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduction of myeloid-derived suppressor cells and induction of M1 macrophages facilitate the rejection of established metastatic disease.
    Sinha P; Clements VK; Ostrand-Rosenberg S
    J Immunol; 2005 Jan; 174(2):636-45. PubMed ID: 15634881
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cross-Talk between Myeloid-Derived Suppressor Cells and Mast Cells Mediates Tumor-Specific Immunosuppression in Prostate Cancer.
    Jachetti E; Cancila V; Rigoni A; Bongiovanni L; Cappetti B; Belmonte B; Enriquez C; Casalini P; Ostano P; Frossi B; Sangaletti S; Chiodoni C; Chiorino G; Pucillo CE; Tripodo C; Colombo MP
    Cancer Immunol Res; 2018 May; 6(5):552-565. PubMed ID: 29523597
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myeloid-specific expression of Ron receptor kinase promotes prostate tumor growth.
    Gurusamy D; Gray JK; Pathrose P; Kulkarni RM; Finkleman FD; Waltz SE
    Cancer Res; 2013 Mar; 73(6):1752-63. PubMed ID: 23328584
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TLR7 expression is decreased during tumour progression in transgenic adenocarcinoma of mouse prostate mice and its activation inhibits growth of prostate cancer cells.
    Han JH; Park SY; Kim JB; Cho SD; Kim B; Kim BY; Kang MJ; Kim DJ; Park JH; Park JH
    Am J Reprod Immunol; 2013 Oct; 70(4):317-26. PubMed ID: 23790156
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of ovarian cancer G protein coupled receptor 1 on the proliferation, migration, and adhesion of human ovarian cancer cells.
    Ren J; Zhang L
    Chin Med J (Engl); 2011 May; 124(9):1327-32. PubMed ID: 21740742
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prostate stem cell antigen vaccination induces a long-term protective immune response against prostate cancer in the absence of autoimmunity.
    Garcia-Hernandez Mde L; Gray A; Hubby B; Klinger OJ; Kast WM
    Cancer Res; 2008 Feb; 68(3):861-9. PubMed ID: 18245488
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IL-12 triggers a programmatic change in dysfunctional myeloid-derived cells within mouse tumors.
    Kerkar SP; Goldszmid RS; Muranski P; Chinnasamy D; Yu Z; Reger RN; Leonardi AJ; Morgan RA; Wang E; Marincola FM; Trinchieri G; Rosenberg SA; Restifo NP
    J Clin Invest; 2011 Dec; 121(12):4746-57. PubMed ID: 22056381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Population alterations of L-arginase- and inducible nitric oxide synthase-expressed CD11b+/CD14⁻/CD15+/CD33+ myeloid-derived suppressor cells and CD8+ T lymphocytes in patients with advanced-stage non-small cell lung cancer.
    Liu CY; Wang YM; Wang CL; Feng PH; Ko HW; Liu YH; Wu YC; Chu Y; Chung FT; Kuo CH; Lee KY; Lin SM; Lin HC; Wang CH; Yu CT; Kuo HP
    J Cancer Res Clin Oncol; 2010 Jan; 136(1):35-45. PubMed ID: 19572148
    [TBL] [Abstract][Full Text] [Related]  

  • 34. iNOS expression in CD4+ T cells limits Treg induction by repressing TGFβ1: combined iNOS inhibition and Treg depletion unmask endogenous antitumor immunity.
    Jayaraman P; Alfarano MG; Svider PF; Parikh F; Lu G; Kidwai S; Xiong H; Sikora AG
    Clin Cancer Res; 2014 Dec; 20(24):6439-51. PubMed ID: 25278453
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polysaccharide Agaricus blazei Murill stimulates myeloid derived suppressor cell differentiation from M2 to M1 type, which mediates inhibition of tumour immune-evasion via the Toll-like receptor 2 pathway.
    Liu Y; Zhang L; Zhu X; Wang Y; Liu W; Gong W
    Immunology; 2015 Nov; 146(3):379-91. PubMed ID: 26194418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of Cationic Amino Acid Transporter 2 Is Required for Myeloid-Derived Suppressor Cell-Mediated Control of T Cell Immunity.
    Cimen Bozkus C; Elzey BD; Crist SA; Ellies LG; Ratliff TL
    J Immunol; 2015 Dec; 195(11):5237-50. PubMed ID: 26491198
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bone marrow macrophages support prostate cancer growth in bone.
    Soki FN; Cho SW; Kim YW; Jones JD; Park SI; Koh AJ; Entezami P; Daignault-Newton S; Pienta KJ; Roca H; McCauley LK
    Oncotarget; 2015 Nov; 6(34):35782-96. PubMed ID: 26459393
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lack of Muc1-regulated beta-catenin stability results in aberrant expansion of CD11b+Gr1+ myeloid-derived suppressor cells from the bone marrow.
    Poh TW; Bradley JM; Mukherjee P; Gendler SJ
    Cancer Res; 2009 Apr; 69(8):3554-62. PubMed ID: 19351842
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Toll-like receptor 3-mediated suppression of TRAMP prostate cancer shows the critical role of type I interferons in tumor immune surveillance.
    Chin AI; Miyahira AK; Covarrubias A; Teague J; Guo B; Dempsey PW; Cheng G
    Cancer Res; 2010 Apr; 70(7):2595-603. PubMed ID: 20233880
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD4
    Liu S; Liu F; Zhang B; Yan P; Rowan BG; Abdel-Mageed AB; Steele C; Jazwinski SM; Moroz K; Norton EB; Wang A; Myers L; Sartor O; Zhang Q
    Prostate; 2020 Jul; 80(10):764-776. PubMed ID: 32356608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.